United Therapeutics signs exclusive pact with Ascendis Pharma

By Admin
United Therapeutics Corporation has signed an exclusive deal with Ascendis Pharma to apply Ascendis Pharmas proprietary TransCon technology platform to...

United Therapeutics Corporation has signed an exclusive deal with Ascendis Pharma to apply Ascendis Pharma’s proprietary TransCon technology platform to United Therapeutics’ treprostinil molecule, the active ingredient in Remodulin® injection.

The company believes that the TransCon technology platform may enable a controlled, long-acting release of a novel, carrier-linked product. This significantly enhances the delivery profile of treprostinil  by establishing a self-injectable alternative for patients who presently use the drug through a continuous infusion pump to treat pulmonary arterial hypertension.

Martine Rothblatt, Ph.D., United Therapeutics’ Chairman and CEO said, “We are thrilled to enter into this license agreement with Ascendis Pharma.” Mr. Rothblatt also said, “The potential to bring another novel therapeutic option to PAH patients represents an exciting new opportunity for Remodulin delivery as we constantly re-charge our mission to better the lives of patients suffering from PAH.” 

Under the terms of the agreement, United Therapeutics will also have exclusive rights to develop prostacyclin, prostacyclin analog and prostacyclin related products to treat PAH using the TransCon technology and will hold worldwide commercial rights to products resulting from the collaboration.

United Therapeutics is a biotechnology company focusing on development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. 


Featured Articles

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

CGI is driving efficiency in healthcare. Hear from Helena Jochberger, at Manufacturing Digital LIVE, a free virtual event on Wednesday 6th December 2023

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI


Healthtech platform CoverSelf extends seed round to US$8.2m

Technology & AI